Itraconazole-associated purpuric drug eruption: a rare adverse effect of a commonly prescribed drug

Purpuric drug eruption (PDE) is a rare drug reaction characterized by purpuric macules, papules and confluent plaques predominantly on the lower extremities. The drugs reported to induce PDE are epidermal growth factor receptor inhibitors, ketoconazole, acetylsalicylic acid, penicillin, sulfonamides, indomethacin, lenalidomide, linezolid and vancomycin. Drug-induced thrombocytopenia, platelet dysfunction and direct toxic effects of the drug on the capillary wall leading to increased capillary fragility are the proposed aetiologies. There is only a single report of itraconazole-induced PDE in the literature to date. We herein present a case of 57-year-old woman with PDE due to itraconazole.

Authors

Institutions

Publication Details

Journal
Skin Health and Disease
Published
2025-03-21
DOI
https://doi.org/10.1093/skinhd/vzaf006
Primary Topic
Autoimmune Bullous Skin Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Itraconazole-associated purpuric drug eruption: a rare adverse effect of a commonly prescribed drug

Supriya Paudel, Sabita Paudel, M Mathur, Sandhya Regmi et al.
Skin Health and Disease
Autoimmune Bullous Skin Diseases
article

Itraconazole-associated purpuric drug eruption: a rare adverse effect of a commonly prescribed drug

Supriya Paudel, Sabita Paudel, M Mathur, Sandhya Regmi, Sambidha Karki, Nabita Bhattarai
article en

Abstract

Purpuric drug eruption (PDE) is a rare drug reaction characterized by purpuric macules, papules and confluent plaques predominantly on the lower extremities. The drugs reported to induce PDE are epidermal growth factor receptor inhibitors, ketoconazole, acetylsalicylic acid, penicillin, sulfonamides, indomethacin, lenalidomide, linezolid and vancomycin. Drug-induced thrombocytopenia, platelet dysfunction and direct toxic effects of the drug on the capillary wall leading to increased capillary fragility are the proposed aetiologies. There is only a single report of itraconazole-induced PDE in the literature to date. We herein present a case of 57-year-old woman with PDE due to itraconazole.

Skin Health and DiseaseVol. 5(2)
College of Medical Sciences (NP)
Good health and well-being
Openalex Percentile: Top 92%
Autoimmune Bullous Skin Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Itraconazole-associated purpuric drug eruption: a rare adverse effect of a commonly prescribed drug — Supriya Paudel, Sabita Paudel, et al. · Skin Health and Disease (2025) | TGRS Research Map | TGRS